Evidence map›Paper›PMID 34325746›Full record

ArticleTranslational neurodegeneration2021

Multivariable clinical-genetic model for predicting dyskinesia in early-onset Parkinson's disease.

Yong-Ping Chen, Ru-Wei Ou, Xiao-Jing Gu, Ling-Yu Zhang, Bei Cao, Yan-Bing Hou, Kun-Cheng Liu, Jun-Yu Lin, Qian-Qian Wei, Bi Zhao and 2 more

Open access · goldAbstract readLetter
In one paragraph

Article in Translational neurodegeneration, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Association Analysis ofFrontiers in genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yong-Ping ChenDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ru-Wei OuDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xiao-Jing GuDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ling-Yu ZhangDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Bei CaoDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yan-Bing HouDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Kun-Cheng LiuDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Jun-Yu LinDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Qian-Qian WeiDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Bi ZhaoDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ying WuDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Hui-Fang ShangDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, 610041, China. hfshang2002@126.com.ORCID 0000-0003-0947-1151
Sichuan University · CN

Funding

1.3.5 project for disciplines of excellence, west china hospital, sichuan university 2019HXFH0461.3.5 project for disciplines of excellence, west china hospital, sichuan university ZYJC180031.3.5 project for disciplines of excellence, west china hospital, sichuan university ZYJC18038national key research and development program of china 2016YFC0901504national key research and development program of china 2018YFC1312001national natural science fund of china 81971188
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Models, GeneticAdultAge of OnsetAntiparkinson AgentsCohort StudiesDyskinesia, Drug-InducedFemaleHumansLevodopaMaleMiddle AgedMultivariate AnalysisParkinson DiseasePredictive Value of TestsAntiparkinson AgentsLevodopa

Identifiers

PMID34325746
PMCPMC8320054
OpenAlexW3184920862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.